1
|
Danpanichkul P, Auttapracha T, Kongarin S, Ponvilawan B, Simadibrata DM, Duangsonk K, Jaruvattanadilok S, Saowapa S, Suparan K, Lui RN, Liangpunsakul S, Wallace MB, Wijarnpreecha K. Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019. J Gastroenterol Hepatol 2024. [PMID: 38772743 DOI: 10.1111/jgh.16620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2024] [Revised: 04/25/2024] [Accepted: 05/03/2024] [Indexed: 05/23/2024]
Abstract
BACKGROUND AND AIM In recent years, there has been a growing incidence of gastrointestinal cancer in young individuals. Despite its significant morbidity and mortality, research on upper gastrointestinal (UGI) cancer in young populations has been relatively limited. Therefore, studies on the epidemiological changes of this cancer are needed. METHODS Using data from the Global Burden of Disease Study 2019, we examined the incidence, death, and disability-adjusted life years (DALYs) from UGI cancers in the young, namely, early-onset esophageal cancer (EOEC) and early-onset gastric cancer (EOGC). These results were stratified by sex, geographical region, country, and sociodemographic index. RESULTS There was a total of 185 140 cases, 120 289 deaths, and 5.70 million DALYs attributable to early-onset UGI cancers globally. From 2010 to 2019, the global incidence, death, and DALYs rates of early-onset UGI cancers decreased. In contrast, the incidence rates increased in both EOEC (+1.15%) and EOGC (+0.21%) in the Eastern Mediterranean region. CONCLUSIONS Over the past decade, the burden of UGI cancer in the young has decreased. However, it has increased in the Eastern Mediterranean region. Further research to elucidate the attributable risk factors in this population is warranted.
Collapse
Affiliation(s)
- Pojsakorn Danpanichkul
- Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
| | | | | | - Ben Ponvilawan
- Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA
| | - Daniel M Simadibrata
- Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA
| | - Kwanjit Duangsonk
- Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
| | | | - Sakditad Saowapa
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
| | - Kanokphong Suparan
- Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
| | - Rashid N Lui
- Department of Clinical Oncology, and Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Institute of Digestive Diseases, The Chinese University of Hong Kong, Hong Kong, SAR, China
| | - Suthat Liangpunsakul
- Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Michael B Wallace
- Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
- Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates
| | - Karn Wijarnpreecha
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA
- BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA
| |
Collapse
|
2
|
Almuhaidib S, Alqahtani R, Alotaibi HF, Saeed A, Alnasrallah S, Alshamsi F, Alqahtani SA, Alhazzani W. Mapping the landscape of medical research in the Arab world countries: A comprehensive bibliometric analysis. Saudi Med J 2024; 45:387-396. [PMID: 38657984 PMCID: PMC11147579 DOI: 10.15537/smj.2024.45.4.20230968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Accepted: 02/28/2024] [Indexed: 04/26/2024] Open
Abstract
OBJECTIVES To describe the productivity, performance, and impact of medical research in the Arab world countries. METHODS We carried out a bibliometric analysis using Clarivate Analytics databases from January 2017 to March 2023. We reported research productivity, national and international research collaboration patterns, impact of Arab medical research output compared to the global average, top medical journals publishing Arab-affiliated research, and performance of the most productive Arab institutions. RESULTS The Arab world contributed 2.72% to global medical research publication, with a citation impact of 11.98 compared to the global impact of 12.02. Qatar, Lebanon, and Saudi Arabia led medical research publications per million population among Arab countries, ranking 26th, 36th, and 37th globally. Medical research publications increased by 87% annually from 2017-2022, with 70% of research originating from Saudi Arabia and Egypt. National collaborations accounted for 15% of Arab world publications, while international collaborations represented 66%. The median impact factor across the top 20 medical journals with Arab-affiliated authors was 5.14, with 50% being quartile one journals. The top 10 Arab-origin medical journals had a median impact factor of 3.13. Approximately 80% of the top 20 Arab institutions were academic, with a median publication count of 3,162.5 and a median citation impact of 14.5. CONCLUSION The study provides insights into the state of medical research in the Arab countries, indicating room for improvement in the region's medical research.
Collapse
Affiliation(s)
- Shadan Almuhaidib
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Rawan Alqahtani
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Haifa F. Alotaibi
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Asma Saeed
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Sahar Alnasrallah
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Fayez Alshamsi
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Saleh A. Alqahtani
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| | - Waleed Alhazzani
- From the Scientific Research Center (Almuhaidib, Alotaibi, Saeed, Alnasrallah, Alhazzani), Ministry of Defense Health Services, from the Department of Business Intelligence and Information Management (Alqahtani), Rumah General Hospital, Riyadh Second Health Cluster, Ministry of Health, from the Organ Transplant Centre of Excellence (Alqahtani), King Faisal Specialist Hospital and Research Centre, from the Department of Critical Care (Alhazzani), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, from the Department of Internal Medicine (Alshamsi), College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates, from the Division of Gastroenterology and Hepatology (Alqahtani), Johns Hopkins University, Baltimore, United States of America, and from the Department of Health Research Methods, Evidence, and Impact (Alhazzani), McMaster University, Hamilton, Canada.
| |
Collapse
|
3
|
Ghazi M, Saleh A, Abdallah M, El Masri D, El Masri J, El Ayoubi LM, Hawi J, Jurjus A. Barriers toward xenotransplantation in Arab World. Xenotransplantation 2024; 31:e12852. [PMID: 38526015 DOI: 10.1111/xen.12852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2024] [Revised: 02/19/2024] [Accepted: 02/22/2024] [Indexed: 03/26/2024]
Abstract
Organ transplant is a crucial therapeutic strategy offering a life-saving and transformative medical intervention. It provides an opportunity to improve their quality of life and increase their lifespan. The shortage of organs remains a critical global challenge, leading to a prolonged waiting times for organ receivers, which contributes to an increase in morbidity and mortality rates. Hence, xenotransplantation offered a promising solution to the global shortage of organs through the use of animal organs, leading to an increase in donor availability, reducing waiting times, minimizing organ trafficking, improving genetic engineering advancements, and driving scientific innovation. Even though xenotransplantation has many benefits in the clinical setting, it has many barriers that are hindering its achievements and constraining its occurrence. Some barriers to xenotransplant are general, such as the immunological barrier, while others are specific to certain regions due to local causes. The Arab region exhibits disparities in clinical settings compared to the global context, marked by the huge economic crisis and a shortage of trained healthcare professionals. Considering the huge resources and advancements needed in the field of xenotransplantation, this review aims to explore the specific barriers toward xenotransplantation in the Arab countries, highlighting the challenges to overcome these barriers.
Collapse
Affiliation(s)
- Maya Ghazi
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
- Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
| | - Aalaa Saleh
- Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
| | - Malak Abdallah
- Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
| | - Diala El Masri
- Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
- Faculty of Medicine, University of Balamand, Koura, Lebanon
| | - Jad El Masri
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
- Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
| | | | - Jihad Hawi
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
| | - Abdo Jurjus
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
| |
Collapse
|
4
|
Al Malak A, El Masri Y, Al Ziab M, Ghazi M, Salameh P. Current State of Clinical Trials Regarding Alveolar Bone Grafting. Cleft Palate Craniofac J 2023:10556656231215164. [PMID: 37990511 DOI: 10.1177/10556656231215164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2023] Open
Abstract
Alveolar ridge defects develop because of surgery, trauma, infection, or congenital malformations. Alveolar ridge defects can be resolved using an osseous replacement. The primary outcomes of osseous replacement are the maintenance of contour; the elimination of dead space, the reduction of postoperative infection; and the increase in bony and soft tissue healing. Recent research shows promising developments in dental bone grafts. This review presents the results of several clinical trials and provides updates on current alveolar bone grafting. In May 2023, we searched Clinicaltrials.gov for interventional clinical trials related to alveolar bone grafting. A total of 66 clinical trials were included using Boolean Operators AND, OR, NOT we used the "advanced search" option with the search terms [Alveolar Bone Grafting] OR [Ridge Preservation] OR [Dental Bone Grafting] OR [Ridge Augmentation]. Reviewed publications are summarized. 28 out of the 66 trials were successfully completed. None of the trials had offered an invitation to enroll, and only one was terminated. Autograft was the most prevalent kind of grafting, at 28 out of 66, more than twice as prevalent as allograft, which ranked second at 12 out of 66. this study shows a lack of variety in location, low results provided, and low clinical trials regarding bone rejection. The focus of published trials was mainly on cleft palate rehabilitation using secondary alveolar bone grafting, and the usage of L-prf, rh-FGF-2, rhBMP2, and hyaluronic acid in association with alveolar bone grafting showed remarkable results concerning bone's osteoconduction, osteoinduction, and osteogenesis.
Collapse
Affiliation(s)
- Ahmad Al Malak
- Faculty of Dental Medicine, Lebanese University, Beirut, Lebanon
| | - Yasmina El Masri
- Faculty of Dental Medicine, Lebanese University, Beirut, Lebanon
| | - Mira Al Ziab
- Faculty of Dental Medicine, Lebanese University, Beirut, Lebanon
| | - Maya Ghazi
- Faculty of Medicine, Lebanese University, Beirut, Lebanon
| | - Pascale Salameh
- School of Medicine, Lebanese American University, Byblos, Lebanon
- Institut National de Santé Publique d'Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Lebanon
- Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus
- Faculty of Pharmacy, Lebanese University, Hadat, Lebanon
| |
Collapse
|
5
|
Al-Shamsi HO, Abu-Gheida I, Sameh K, Tahoun NE, Musallam KM. Arab Countries and Oncology Clinical Trials: A Bibliometric Analysis. Cancers (Basel) 2023; 15:4428. [PMID: 37760398 PMCID: PMC10526906 DOI: 10.3390/cancers15184428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Revised: 08/29/2023] [Accepted: 08/30/2023] [Indexed: 09/29/2023] Open
Abstract
The increasing cancer burden is a major health concern in Arab countries with cross-regional variations in cancer profiles. Given the limited oncology research output and scarce data on cancer trial participation in the Arab region, this study explored the therapeutic cancer trial landscape in Arab countries over the past 20 years. A bibliometric analysis of the PubMed database was conducted on primary publications of therapeutic trials with a participating Arab center. Arab countries participated in 320 published cancer-related therapeutic trials (2000-2021). During this period, there was a consistent increase in the number of trials, sample size, multiregional site participation, and number of randomized trials. However, most trials were small, did not receive external funding, and included a single Arab site. Compared with Arab-only trials, trials with joint non-Arab sites were larger (p = 0.003) and more likely to be externally funded (p < 0.001). Citation numbers and journal impact factors were higher in trial publications with joint non-Arab authorship than those without (p < 0.001, for both). Despite improving conduct and publication records of oncology trials with Arab centers, cancer trial participation remains limited in Arab countries. Concerted efforts are required to encourage sponsorship and international collaboration in this region.
Collapse
Affiliation(s)
- Humaid O. Al-Shamsi
- Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi P.O. Box 92510, United Arab Emirates; (I.A.-G.); (K.M.M.)
- College of Medicine, Gulf Medical University, Ajman P.O. Box 4184, United Arab Emirates
- Emirates Oncology Society, Dubai P.O. Box 6600, United Arab Emirates
- College of Medicine, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates
- Gulf Cancer Society, Alsafa P.O. Box 2311, Kuwait
| | - Ibrahim Abu-Gheida
- Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi P.O. Box 92510, United Arab Emirates; (I.A.-G.); (K.M.M.)
| | - Kareem Sameh
- Pfizer Gulf FZ LLC, Dubai Media City, Dubai P.O. Box 502749, United Arab Emirates; (K.S.); (N.E.T.)
| | - Nouran E. Tahoun
- Pfizer Gulf FZ LLC, Dubai Media City, Dubai P.O. Box 502749, United Arab Emirates; (K.S.); (N.E.T.)
| | - Khaled M. Musallam
- Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi P.O. Box 92510, United Arab Emirates; (I.A.-G.); (K.M.M.)
| |
Collapse
|
6
|
Rehan ST, Ul Hussain H, Nihal K, Sukaina M, Khan Z, Nashwan AJ. Global Monkeypox Virus Outbreak 2022: A Bibliometric Analysis. Cureus 2023; 15:e37107. [PMID: 37168183 PMCID: PMC10166297 DOI: 10.7759/cureus.37107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/31/2023] [Indexed: 04/07/2023] Open
Abstract
Monkeypox is a rare zoonotic disease caused by the monkeypox virus, which spreads by direct contact mainly, thus having the propensity to cause future epidemics. The current review aimed to provide an up-to-date literature analysis for evaluating scientific data on monkeypox. A bibliometric analysis was conducted through eight electronic databases. The search period was from May 2022 to December 2023. All the articles were exported to Mendeley (Elsevier, Amsterdam, Netherlands). The literature search resulted in 415 relevant research articles. The growth of publications gradually rose, initiated in January 2022, leading to a rapid upsurge in May 2022. A total of 409 documents reported the number of citations, with two articles documenting the highest number, ranging from 146-150 and 216-220. The European region (EURO) dominated in publishing research articles on monkeypox, with the United States having the highest number of reports (n = 41; 9.87%), followed by the United Kingdom (n = 35; 8.43%) and Italy (n = 15; 3.61%). There were 82 funding agencies that funded 44 research articles, whereas 371 were not funded by any funding agency. Our analysis has presented the outline of the research articles published on monkeypox virus-related literature during the current outbreak. Research articles should be financially and administratively supported. Future research is required to expand research on the monkeypox virus, as there is a growing demand for original articles.
Collapse
Affiliation(s)
- Syeda Tayyaba Rehan
- Department of Internal Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK
| | - Hassan Ul Hussain
- Department of Medicine, Dow University of Health Sciences, Karachi, PAK
| | - Kanwal Nihal
- Department of Medicine, Dow University of Health Sciences, Karachi, PAK
| | - Mahnoor Sukaina
- Department of Medicine, Karachi Medical and Dental College, Karachi, PAK
| | - Zayeema Khan
- Department of Internal Medicine, Dow University of Health Sciences, Karachi, PAK
| | | |
Collapse
|
7
|
Liu Z, Wan H, Tan Y, Li D, Huang J, Zhang C, Liu F, Qin B. Bibliometric and visual analyses of trends in the field of T cell exhaustion research: Findings from 2000 to 2022. Int J Immunopathol Pharmacol 2023; 37:3946320231215219. [PMID: 37975658 PMCID: PMC10656813 DOI: 10.1177/03946320231215219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 11/01/2023] [Indexed: 11/19/2023] Open
Abstract
BACKGROUND T cell exhaustion refers to a state wherein T cells become less functional as a result of their prolonged exposure to cognate antigens. A wealth of T cell exhaustion-focused research has been conducted in recent decades, transforming the current understanding of this biologically relevant process. However, there have not been any comprehensive bibliometric analyses to date focused on clarifying the T cell exhaustion-related research landscape. Here, a bibliometric analysis was thus conducted with the goal of better elucidating the current state of knowledge and emerging research hotspots in this field. METHODS The Web of Science Core Collection was searched for articles and reviews related to T cell exhaustion, with the CiteSpace and VOSviewer programs then being employed to analyze the countries, institutions, authors, references, and keywords associated with studies in this research space. RESULTS In total, 2676 studies were incorporated in this analysis, highlighting progressive annual increases in the number of T cell exhaustion-focused publications over the study period. These publications were affiliated with 3117 institutions in 85 countries, with the USA and China being the largest contributors to the field. Of the 18,032 authors associated with these publications, E. John Wherry exhibited the highest publication count and the greatest citation frequency. Keyword analyses indicated that immunotherapy, T cell exhaustion, and PD-1 are the dominant foci for T cell exhaustion-related research. CONCLUSION These findings highlight the importance of collaborations among institutions and nations in order to further propel novel studies of T cell exhaustion. Efforts to unravel the signal transduction and transcriptional mechanisms underlying the onset of T cell exhaustion were also identified as an emerging hotspot in this field. Ultimately, these results support the pivotal status of T cell exhaustion research as a key direction for immunotherapeutic research and development efforts in the coming years.
Collapse
Affiliation(s)
- Ziling Liu
- Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China
- Shenzhen Aier Ophthalmic Technology Institute, Shenzhen, China
- The Second Clinical Medical College, Jinan University, Shenzhen, China
| | - Huan Wan
- Institute of Biopharmaceutics and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, China
| | - Yao Tan
- Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China
| | - Deshuang Li
- Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China
| | - Jianguo Huang
- Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China
| | - Chuanhe Zhang
- Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China
| | - Fangyuan Liu
- Institute of Biopharmaceutics and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, China
| | - Bo Qin
- Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China
- The Second Clinical Medical College, Jinan University, Shenzhen, China
| |
Collapse
|